SMI Expanded

SMI Expanded handeln
1.861,45 PKT +8,57 PKT +0,46 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0019399861


Analysen zu SMI Expanded-Werten

Datum Rating Analyst
21.02.12 ABB (Asea Brown Boveri) overweight J.P. Morgan Cazenove
21.02.12 Schindler buy Sarasin Research
21.02.12 Swatch (I) buy Deutsche Bank AG
21.02.12 Givaudan neutral Credit Suisse Group
21.02.12 ABB (Asea Brown Boveri) outperform Cheuvreux SA
21.02.12 Swisscom buy Nomura
21.02.12 Julius Bär buy Sarasin Research
21.02.12 Zurich Insurance outperform RBC Capital Markets
21.02.12 Zurich Insurance halten Independent Research GmbH
20.02.12 Holcim neutral Citigroup Corp.
20.02.12 Clariant buy Citigroup Corp.
20.02.12 Zurich Insurance buy ING
20.02.12 ABB (Asea Brown Boveri) kaufen Hamburger Sparkasse AG (Haspa)
20.02.12 UBS halten Hamburger Sparkasse AG (Haspa)
20.02.12 Nestlé halten Independent Research GmbH
20.02.12 Givaudan neutral UBS AG
17.02.12 EMS-CHEMIE buy Sarasin Research
17.02.12 Zurich Insurance neutral Merrill Lynch & Co., Inc.
17.02.12 Givaudan sell Citigroup Corp.
17.02.12 Swatch (I) buy Sarasin Research
17.02.12 Givaudan overweight J.P. Morgan Cazenove
17.02.12 ABB (Asea Brown Boveri) overweight J.P. Morgan Cazenove
17.02.12 Zurich Insurance buy Nomura
17.02.12 ABB (Asea Brown Boveri) halten Independent Research GmbH
16.02.12 Clariant overweight Barclays Capital
16.02.12 Swisscom buy Société Générale Group S.A. (SG)
16.02.12 Nestlé hold ING
16.02.12 Zurich Insurance buy Sarasin Research
16.02.12 Givaudan neutral Sarasin Research
16.02.12 Clariant sell Société Générale Group S.A. (SG)
15.02.12 Swisscom neutral Sarasin Research
15.02.12 Clariant buy Sarasin Research
15.02.12 Swiss Re equal-weight Morgan Stanley
14.02.12 UBS underperform Exane-BNP Paribas SA
14.02.12 UBS underperform Exane-BNP Paribas SA
14.02.12 Roche neutral Citigroup Corp.
14.02.12 Geberit halten Öko Invest
14.02.12 UBS overweight HSBC
14.02.12 UBS overweight HSBC
13.02.12 Zurich Insurance neutral UBS AG